Nuchev Ltd (ASX: NUC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Nuchev Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $16.83 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 146.34 million
Earnings per share -0.116
Dividend per share N/A
Year To Date Return -28.95%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Nuchev Ltd (ASX: NUC)
    Latest News

    Share Gainers

    Why Iron Road, Nuchev, Telix, & Treasury Wine shares are pushing higher today

    Iron Road Limited (ASX:IRD) and Treasury Wine Estates Ltd (ASX:TWE) shares are two of four pushing notably higher on Thursday...

    Read more »

    ⏸️ Shares to Watch

    Should you buy these 2 ASX dairy shares instead of A2 Milk?

    Could you replace Kiwi giant A2 Milk Company Ltd (ASX: A2M) with these 2 ASX dairy shares?

    Read more »

    $10, $20 and $50 noted planted in the dirt signifying asx growth shares
    Growth Shares

    A2 Milk and 1 other top ASX growth share to buy this month

    Here we look at 2 quality ASX growth shares to consider adding to your ASX share portfolio: A2 Milk Company…

    Read more »

    laptop, newspaper, ipad, coffee and hands holding iphone
    Share Market News

    3 quarterly updates you might have missed: Champion Iron, Life360, & Nuchev

    It isn't just St Barbara Ltd (ASX:SBM) and IGO Ltd (ASX:IGO) releasing quarterly updates on Wednesday. Did you see these…

    Read more »

    Share Market News

    Why I'd buy and hold a2 Milk shares until 2025

    Despite their recent growth, here's why I believe a2 Milk Company Ltd (ASX: A2M) shares are a great buy and…

    Read more »

    line graph superimposed over milking cows, a2 milk share price
    Share Market News

    Is the a2 Milk share price too high to buy?

    The A2 Milk share price has been one of the standout performers during the coronavirus crisis. Is it too late…

    Read more »

    a woman
    Share Market News

    Fund managers have been buying these ASX shares this week

    Fund managers have been buying ASX shares this week. Here's what they have been adding to their portfolios...

    Read more »

    a woman
    Share Market News

    This ASX infant formula share just reported explosive growth. Could it be the next a2 Milk?

    Could Nuchev Ltd (ASX: NUC) become the next A2 Milk Company Ltd (ASX: A2M)?

    Read more »

    a woman
    Share Market News

    2 ASX 200 companies playing a vital role in the coronavirus crisis

    Here, we look at 2 ASX companies playing a vital role in the coronavirus crisis – Metcash Limited (ASX: MTS)…

    Read more »

    a woman
    Share Market News

    3 ASX shares to buy with $3,000

    Whether you're buying shares for the first time or looking to add to your portfolio, here are 3 ASX share…

    Read more »

    a woman
    Share Market News

    3 top ASX growth shares to diversify your portfolio

    Here's why A2 Milk Company (ASX: A2M) and these other 2 top ASX growth shares are my picks for a…

    Read more »

    a woman
    Share Market News

    3 ASX growth shares to buy and hold beyond 2025

    Here's why I think these 3 ASX growth shares are great options to buy and hold until 2025 and beyond.

    Read more »

    NUC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Nuchev Ltd

    Nuchev Ltd is a globally-oriented food business focused on developing, marketing, and selling a range of premium Australian made goat nutritional products. Its primary products include those branded under the Oli6 Bio Practica and MedicineTree and a number of globally recognized European brands sold under exclusive license in Australia and New Zealand by bWellness.

    NUC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    18 Nov 2024 $0.12 $0.00 0.00% 5,000 $0.12 $0.12 $0.12
    11 Nov 2024 $0.12 $-0.02 -14.81% 91,500 $0.14 $0.14 $0.12
    29 Oct 2024 $0.14 $0.00 0.00% 155 $0.14 $0.14 $0.14

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    29 Jul 2024 Ben Dingle Expiry 1,646,090 $296,296
    Options expired.
    27 Jun 2024 Craig Silbery Issued 2,271,561 $354,363
    Rights issue.
    27 Jun 2024 Craig Silbery Issued 1,342,766 $209,471
    Rights issue.
    27 Jun 2024 Ben Dingle Issued 5,769,231 $900,000
    Rights issue.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Ben McFarlane Dingle Executive DirectorExecutive Chairman Apr 2013
    Mr Dingle founded Nuchev and was CEO between 2013 and October 2022. Ben is recognized as a highly connected, large-scale dairy innovator and leader. He has commercial experience in the wider dairy nutritional sector, having co-founded New Zealand's Synlait Group in 1999, and later played a pivotal role in steering the IPO of Synlait Milk in 2013. Ben was also instrumental in the creation and management of a portfolio encompassing expansive dairy operations on the Canterbury Plains, which included approximately 15,000 cows. In this role, he established and implemented innovative irrigation schemes, and the incorporation of world best farming practices. Before co-founding Synlait Milk, Ben owned and managed a portfolio of dairy operations in the Waikato region.
    Ms Elizabeth Smith (Liz) Non-Executive Director Jul 2024
    Ms Smith has executive career includes Corporate Finance Partner roles at William Buck and Grant Thornton, as well as audit experience at Ernst & Young. L Smith is on the Board of the Australian Red Cross Pureprofile (ASX:PPL) and BikeExchange (formerly ASX: BEX). L Smith has skills in finance and accounting, strategy, M&A, risk and governance and experience advising businesses. She has worked across a range of industries (including food and fast-moving consumer goods) and for businesses ranging from small privately owned companies to large ASX listed entities.
    Mr Craig Silbery Non-Executive Director Oct 2023
    Mr Silbery has been a Non-Executive Director of Nuchev since October 2023. Craig is a respected entrepreneur who established and led Life-Space Group from start-up to a successful exit with the sale to Guangzhou based By-Health in 2018. He built Life-Space around a core foundation of innovative probiotic formulas for infants and pregnant women based on Human Microbiome science.
    Mr Nathan Alexander Xavier Cheong Non-Executive Director Sep 2024
    Mr Cheong brings over 20 years of experience within the medicine industry. Nathan Cheong is a Director, Managing Director and CEO. His executive career includes CEO roles at Melrose Group and LifeSpace Group, Managing Director roles at Designs for Health, Blackmores owned BioCeuticals practitioner only brand, Global Therapeutics, and as General Manager and Director at Herbs of Gold (formerly ASX:VSC). Nathan has also served as a Non-Executive Director on the Board of Complementary Medicines Australia.
    Ms Tamara Barr Company Secretary Feb 2022
    -
    Mr Michael(Mick) Loe Myers Chief Executive Officer Dec 2023
    -
    Michael(Mick) Loe Myers Chief Executive Officer
    -
    Eddie MacDonald Chief Financial Officer
    -
    Helen Hovenga Chief People Officer
    -
    Tamara Barr Company Secretary
    -
    Roberta Barbiellini General Manager bWellness
    -
    Simon Heagney General Manager Supply Chain
    -
    Scott Koetsier Head of Sales and Business Development
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    H&S Investments Australia Pty Ltd H&S Investment Unit A/C> (including Brauer) 66,818,031 45.66%
    Ben Dingle 37,853,680 25.87%
    Hsbc Custody Nominees (Australia) Limited 12,564,873 8.59%
    Mr Craig Silbery 5,035,370 3.44%
    Mr Craig Silbery Silbery Super Fund A/C> 2,271,561 1.55%
    Gigo Investment Pty Ltd Gigo A/C> 1,374,949 0.94%
    CW Investment Holdings Pty Ltd CW Investment Holdings A/C> 1,030,000 0.70%
    Kirwood Capital Direct Investments 1 Pty Ltd Kirwood Cap Direct Invest 1> 1,000,000 0.68%
    Finclear Services Pty Ltd Superhero Securities A/C> 956,029 0.65%
    Justin Breheny 937,008 0.64%
    Powers Pty Ltd 900,000 0.62%
    Top End Enterprises Pty Ltd Atkins Family A/C> 892,644 0.61%
    Ataturk Investments Pty Ltd 646,031 0.44%
    Bk Custodian Pty Ltd Earle/Blackwell Family A/C> 484,356 0.33%
    MF & SA Super Pty Ltd MF & SA Super A/C> 477,570 0.33%
    Daho Pty Ltd The DHB S/F A/C> 450,000 0.31%
    Souvenir Paradise Pty Ltd 400,000 0.27%
    C&L Chen Pty Ltd C&L Chen Li SF A/C> 322,159 0.20%
    Mr Pynith Charernsirivathin & Mrs Zina Christina Charernsirivathin 300,000 0.21%
    Mr John Leon Trabinger 299,999 0.21%

    Profile

    since

    Note